765-24-3-021-0910 -Hines CMOP MESALAMINE
ID: 36C77024Q0404Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/c0a58e8ea2824405b1e440bf0a4208fc/view
Timeline
    Description

    The Department of Veterans Affairs is seeking vendors to provide Mesalamine 800MG EC Tablets for the Hines CMOP facility under the solicitation RFQ 36C77024Q0404. Interested parties must submit their quotes by September 19, 2024, and ensure that all pharmaceuticals have a minimum one-year expiration from the delivery date, adhering to the Trade Agreements Act regulations. This procurement is crucial for maintaining the supply of essential medications to veterans, emphasizing compliance with federal regulations and the integrity of the pharmaceutical supply chain. Vendors are required to register in SAM.gov and submit a comprehensive solicitation package, including a signed SF1449 form, pricing schedule, and proof of a state wholesale distributor license. For further inquiries, contact Sarah Fry at sarah.fry2@va.gov or call 913-758-9935.

    Point(s) of Contact
    Sarah Fry
    (913) 758-9935
    sarah.fry2@va.gov
    Files
    Title
    Posted
    S02_Pricing Schedule_Q0404.xlsx
    The document outlines a Request for Quotation (RFQ) for the VA CMOP Hines facility, specifically under RFQ 36C77024Q0404. Vendors must submit their quotes by September 19, 2024, with a required delivery timeline of 10 days after receipt of order. Key documentation includes a signed SF1449 solicitation cover page, a completed quote spreadsheet, proof of a state wholesale distributor license, and a Trade Agreement Certificate. Vendors must provide one quote only and detail any adjustments related to the National Drug Code (NDC) counts. It's essential that all pharmaceuticals and medical supplies have a minimum one-year expiration from the delivery date. The document specifies required items, quantities, and pricing for MESALAMINE 800MG EC TAB, with adherence to Trade Agreement Act regulations. This RFQ emphasizes the VA's procurement process for necessary medical supplies, ensuring compliance with federal regulations and maintaining product integrity.
    S02_RFQ_36C77024Q0404.pdf
    The document pertains to a Request for Proposal (RFP) for the procurement of pharmaceuticals, specifically Mesalamine 800MG EC Tablets, by the Department of Veterans Affairs. The acquisition is set as unrestricted, with a due date for offers on September 19, 2024. Vendors must be registered in SAM.gov and provide comprehensive solicitation packages that include a signed SF1449 form, a pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act (TAA) certificate, among other requirements. The document outlines specific delivery terms, including that products must be shippable via USPS, and stipulates that all items must include bar code labeling per GS1-128 or HIBCC standards. Vendors are required to provide firm commitments on availability and pricing before purchase order placement. It emphasizes compliance with the Drug Supply Chain Security Act and outlines guidelines for handling recalls. The document further lays out payment and invoicing procedures, indicating that payments will be electronically transferred unless otherwise stated. This procurement process highlights the VA's commitment to obtaining quality pharmaceuticals while ensuring regulatory compliance and efficient supply chain management.
    S03_PRE_SOL_Q0404.pdf
    The Department of Veterans Affairs (VA) is preparing to issue a presolicitation notice for the procurement of Mesalamine 800MG EC tablets, with a quantity of 288 units for delivery to the Hines Consolidated Mail Outpatient Pharmacy (CMOP) in Illinois. This opportunity is categorized under full and open competition within Product Service Code 6505, relating to drugs and biologicals, and falls under the NAICS code 325412 for pharmaceutical preparation manufacturing. Interested vendors must respond by September 19, 2024, and provide various documentation, including a signed SF1449 form, pricing schedule, state wholesale distributor license, and a Trade Agreement Act (TAA) certificate if applicable. The estimated issue date for the solicitation is September 17, 2024, and the awarded delivery timeframe is set for 10 days after order acknowledgment. The notice emphasizes that only bids from registered and compliant vendors will be considered and all submissions must adhere to the specified requirements to avoid being deemed non-compliant.
    Lifecycle
    Title
    Type
    765-24-3-021-0910 -Hines CMOP MESALAMINE
    Presolicitation
    765-24-3-021-0910 -Hines CMOP MESALAMINE
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    8145--Medication Return Envelopes (VA-24-00012799)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized as drugs and biologicals, indicating the importance of these tablets in the healthcare services provided to veterans. Interested vendors should reach out to the primary contact, Contracting Officer Adrienne A Albachiara, via email at Adrienne.Albachiara@va.gov for further details regarding the submission process and any deadlines associated with this opportunity.
    Q517--Hazardous Compounding
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for hazardous compounding services to support the Gulf Coast Veterans Health Care System, specifically for providing compounded hazardous chemotherapy agents at its facilities in Biloxi, MS, and Pensacola, FL. The contract will be structured as a firm-fixed price, indefinite-delivery, indefinite-quantity agreement, with a base period from October 1, 2024, to September 30, 2025, and the option for four additional one-year extensions. This procurement is critical for ensuring the timely and compliant delivery of essential medical treatments to veterans, adhering to FDA and USP standards while emphasizing quality assurance and regulatory compliance. Interested contractors should submit their proposals and past performance questionnaires by 12 PM CT on September 20, 2024, and can direct inquiries to Contracting Officer Tina L. Harris at Tina.Harris3@va.gov.
    FMC Devens - NDC 66215-0602-06
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons at FMC Devens, is seeking quotes for the procurement of specific pharmaceutical products, including Selexipag and Treprostinil, under solicitation number 15B20524Q00000040. The requirement emphasizes the need for brand name medications, with detailed specifications including quantities and National Drug Codes for each item. These cardiovascular agents are critical for the health management of inmates, highlighting the importance of timely and compliant pharmaceutical supply. Interested vendors must submit their quotes by 10:00 a.m. Eastern Standard Time on September 20, 2024, to Charles Coushaine at ccoushaine@bop.gov, ensuring compliance with all applicable federal regulations and contract clauses.
    R408--FY24 IVC PHARMACY BENEFIT MANAGER
    Active
    Veterans Affairs, Department Of
    Presolicitation VETERANS AFFAIRS, DEPARTMENT OF is seeking Pharmacy Benefit Management Services for Veteran Family Member Programs. These services are intended to support the Department of Veterans Affairs (VA) Commodities and Services Acquisition Service (CSAS) and the Department of Veterans Affairs (DVA), Veteran Family Member Program (VFMP). The services will involve the management of pharmacy benefits for veteran family members. The solicitation will result in the award of a single award indefinite-delivery-indefinite-quantity (IDIQ) contract. Interested offerors must have a valid Contractor Unique Entity ID and be registered in the Systems for Award Management (SAM) database. The solicitation is expected to be issued on June 15, 2023, with a closing date of July 13, 2023. Proposals will be evaluated based on Technical Capability, Past Performance, Veteran Involvement, and Price. For more information, contact Sandra McAnany at (303) 215-5246 or sandra.mcanany@va.gov.